Prolonged insulin treatment inhibits GH signaling via STAT3 and STAT1

Journal of Endocrinology

Volumn 184, Issue 3, 2005, Pages 481-492

  Xu, Jie ^a   Ji, Shaonin ^a   Venable, Derwei Y ^a   Franklin, John L ^a   Messina, Joseph L ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN;

ANIMAL CELL; ARTICLE; BODY COMPOSITION; BODY GROWTH; CELL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FEEDBACK SYSTEM; HEPATOMA CELL; HYPERINSULINEMIA; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CHEMILUMINESCENT MEASUREMENTS; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH HORMONE; INSULIN; LIVER; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; RATS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANS-ACTIVATORS;

EID: 15844366242     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05977     Document Type: Article

References (55)

1. Aithaud G, Grimaldi P & Négrel R 1994 Hormonal regulation of adipose differentiation. Trends in Endocrinology and Metabolism 5 132-136.
2. Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C & Poli V 2001 Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation in the liver. Molecular and Cellular Biology 21 1621-1632.
3. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN & Carter-Su C 1993 Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74 237-244.
4. Barthel A & Schmoll D 2003 Novel concepts in insulin regulation of hepatic gluconeogenesis. American Journal of Physiology-Endocrinology and Metabolism 285 E685-E692.
5. Bergad PL, Shih HM, Towle HC, Schwarzenberg SJ & Berry SA 1995 Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites. Journal of Biological Chemistry 270 24903-24910.
6. Bjorntorp P 1997 Hormonal control of regional fat distribution. Human Reproduction 12 Suppl 1 21-25.
7. Blumberg D, Hochwald S, Brennan MF & Burt M 1995 Preliminary report: Interleukin-6 stimulates gluconeogenesis in primary cultures of rat hepatocytes. Metabolism 44 145-146.
8. Campbell GS, Meyer DJ, Raz R, Levy DE, Schwartz J & Carter-Su C 1995 Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. Journal of Biological Chemistry 270 3974-3979.
9. Campos SP & Baumann H 1992 Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Molecular and Cellular Biology 12 1789-1797.
10. Campos SP, Wang Y & Baumann H 1996 Insulin modulates STAT3 protein activation and gene transcription in hepatic cells. Journal of Biological Chemistry 271 24418-24424.
11. Carter-Su C, Schwartz J & Smit LS 1996 Molecular mechanism of growth hormone action. Annual Review of Physiology 58 187-207.
12. Ceresa BP, Horvath CM & Pessin JE 1997 Signal transducer and activator of transcription-3 serine phosphorylation by insulin is mediated by a Ras/Raf/MEK-dependent pathway. Endocrinology 138 4131-4137.
13. Chen CM, Clarkson RWE, Xie Y, Hume DA & Waters MJ 1995 Growth hormone and colony-stimulating factor 1 share multiple response elements in the c-fos promoter. Endocrinology 136 4505-4516.
14. Choi HK & Waxman DJ 2000 Pulsatility of growth hormone (GH) signalling in liver cells: role of the JAK-STAT5b pathway in GH action. Growth Hormone and IGF Research 10 Suppl B S1-S8.
15. Coffer PJ, Van Puijenbroek A, Burgering BM, Klop-de JM, Koenderman, Bos JL & Kruijer W 1997 Insulin activates Stat3 independently of p21 ras-ERK and PI-3K signal transduction. Oncogene 15 2529-2539.
16. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW & Hurley D 1998 The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. Journal of Clinical Endocrinology and Metabolism 83 107-116.
17. Dandona P, Aljada A & Bandyopadhyay A 2004 Inflammation: the link between insulin resistance, obesity and diabetes. Trends In Immunology 25 4-7.
18. Delesque-Touchard N, Park SH & Waxman DJ 2000 Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b. Proposed model for female specific expression of CYP2C12 in adult rat liver. Journal of Biological Chemistry 275 34173-34182.
19. Dusanter-Fourt I, Muller O, Ziemiecki A, Mayeux P, Drucker B, Djiane J, Wilks A, Harpur AG, Fischer S & Gisselbrecht S 1994 Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells. EMBO Journal 13 2583-2591.
20. Frank SJ & Messina JL 2002 Growth Hormone Receptor. In Cytokine Reference Data Book On-Line, Eds JJ Oppenheim & M Feldman. London: Academic Press, Harcourt.
21. Freeth JS, Silva CM, Whatmore AJ & Clayton PE 1998 Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children. Endocrinology 139 20-28.
22. Fujita N, Sakamaki H, Uotani S, Takahashi R, Kuwahara H, Kita A, Oshima K, Yamasaki H, Yamaguchi Y & Eguchi K 2003 Intracerebroventricular administration of insulin and glucose inhibits the anorectic action of leptin in rats. Experimental Biology and Medicine 228 1156-1161.
23. Griffin EE & Miller LL 1974 Effects of hypophysectomy of liver donor on net synthesis of specific plasma proteins by the isolated perfused rat liver. Modulation of synthesis of albumin, fibrinogen, alpha 1-acid glycoprotein, alpha 2-(acute phase)-globulin, and haptoglobin by insulin, cortisol, triiodothyronine, and growth hormone. Journal of Biological Chemistry 249 5062-5069.
24. Gronowski AM & Rotwein P 1994 Rapid changes in nuclear protein tyrosine phosphorylation after growth hormone treatment in vivo. Identification of phosphorylated mitogen-activated protein kinase and STAT91. Journal of Biological Chemistry 269 7874-7878.
25. Han Y, Leaman DW, Watling D, Rogers NC, Groner B, Kerr IM & Wood WISGR 1996 Participation of JAK and STAT proteins in growth hormone-induced signaling. Journal of Biological Chemistry 271 5947-5952.
26. Herrington J, Smit LS, Schwartz J & Carter-Su C 2000 The role of STAT proteins in growth hormone signaling. Oncogene 19 2585-2597.
27. Ho KK, O'Sullivan AJ & Hoffman DM 1996 Metabolic actions of growth hormone in man. Endocrine Journal 43 S57-S63.
28. Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, Leroith D, Takeda K, Akira S & Kasuga M 2004 Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nature Medicine 10 168-174.
29. Ji S, Guan R, Frank SJ & Messina JL 1999 Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway. Journal of Biological Chemistry 274 13434-13442.
30. Klasing KC 1988 Nutritional aspects of leukocytic cytokines. Journal of Nutrition 118 1436-1446.
31. Kuwahara H, Uotani S, Abe T, Degawa-Yamauchi M, Takahashi R, Kita A, Fujita N, Ohshima K, Sakamaki H, Yamasaki H, Yamaguchi Y & Eguchi K 2003 Insulin attenuates leptin-induced STAT3 tyrosine-phosphorylation in a hepatoma cell line. Molecular and Cellular Endocrinology 205 115-120.
32. Lahuna O, Rastegar M, Maiter D, Thissen JP, Lemaigre FP & Rousseau GG 2000 Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone. Molecular Endocrinology 14 285-294.
33. Laron Z 1995 Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. Journal of Clinical Endocrinology and Metabolism 80 1526-1531.
34. Lewis UJ 1992 Growth hormone: What is it and what does it do? Trends in Endocrinology and Metabolism 3 117-121.
35. Luger A, Prager R, Gaube S, Graf H, Klauser R & Schernthaner G 1990 Decreased peripheral insulin sensitivity in acromegalic patients. Experimental and Clinical Endocrinology 95 339-343.
36. Lutticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K & Taga T 1994 Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263 89-92.
37. Maassen JA & Ouwens DM 1997 Mechanism of insulin action. Frontiers of Hormone Research 22 201-221.
38. Meyer DJ, Campbell GS, Cochran BH, Argetsinger LS, Larner AC, Finbloom DS, Carter-Su C & Schwartz J 1994 Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor. Journal of Biological Chemistry 269 4701-4704.
39. Moore LG, Pfeffer A, Ng Chie W, Miller HA, Rogers KM & O'Keeffe LE 1995 Induction of an acute phase response in lambs causes an increase in plasma levels of GH and IGF-I. Journal of Endocrinology 144 243-250.
40. Myers MG, Jr, Sun XJ & White MF 1994 The IRS-1 signaling system. Trends in Biochemical Sciences 19 289-293.
41. Nakae J & Accili D 1999 The mechanism of insulin action. Journal of Pediatric Endocrinology and Metabolism 12 Suppl 3 721-731.
42. O'Riordain MG, Ross JA, Fearon KCH, Maingay J, Farouk M, Garden QJ & Carter DC 1995 Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. American Journal of Physiology - Endocrinology and Metabolism 269 E323-E330.
43. Phornphutkul C, Frick GP, Goodman HM, Berry SA & Gruppuso PA 2000 Hepatic growth hormone signaling in the late gestation fetal rat. Endocrinology 141 3527-3533.
44. Ram PA, Park SH, Choi HK & Waxman DJ 1996 Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver - differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. Journal of Biological Chemistry 271 5929-5940.
45. Robertson LM, Kerppola TK, Vendrell M, Luk D, Smeyne RJ, Bocchiaro C, Morgan JI & Curran T 1995 Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron 14 241-252.
46. Schaefer F, Chen Y, Tsao T, Nouri P & Rabkin R 2001 Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. Journal of Clinical Investigation 108 467-475.
47. Stred SE & Messina JL 2003 Identification of hemopexin as a GH-regulated gene. Molecular and Cellular Endocrinology 204 101-110.
48. Taylor SI 1999 Deconstructing type 2 diabetes. Cell 97 9-12.
49. Thompson BJ, Shang CA & Waters MJ 2000 Identification of genes induced by growth hormone in rat liver using cDNA arrays. Endocrinology 141 4321-4324.
50. Thompson D, Harrison SP, Evans SW & Whicher JT 1991 Insulin modulation of acute-phase protein production in a human hepatoma cell line. Cytokine 3 619-626.
51. Waxman DJ 2000 Growth hormone pulse-activated STAT5 signalling: a unique regulatory mechanism governing sexual dimorphism of liver gene expression. Novartis Foundation Symposium 227 61-74.
52. Waxman DJ, Ram PA, Park SH & Choi HK 1995 Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation, of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. Journal of Biological Chemistry 270 13262-13270.
53. White MF & Kahn CR 1994 The insulin signaling system. Journal of Biological Chemistry 269 1-4.
54. Whitehead JP, Clark SF, Urso B & James DE 2000 Signalling through the insulin receptor. Current Opinion in Cell Biology 12 222-228.
55. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O & Ihle JN 1993 JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74 227-236.